Inari Medical, Inc. (NARI)

38,42 +0,35 (+0,92%) Alla chiusura: 04:00PM EDT

Inari Medical, Inc.

6001 Oak Canyon
Suite 100
Irvine, CA 92618
United States
877 923 4747
https://www.inarimedical.com

Settore/i: Healthcare
Settore: Medical Devices
Impiegati a tempo pieno: 1.300

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Andrew J. Hykes	CEO, President & Director	1,54M	N/D	1973
Mr. Mitchell C. Hill	Chief Financial Officer	864,63k	4,78M	1959
Dr. Thomas M. Tu M.D.	Chief Medical Officer	865,63k	1,17M	1973
Mr. Paul A. Koehn	Senior Vice President of Operations	N/D	N/D	1963
Mr. Kevin Strange	Senior Vice President of Finance, Accounting, Strategy & Business Development	N/D	N/D	N/D
Mr. John Hsu C.F.A.	Vice President of Investor Relations	N/D	N/D	N/D
Ms. Angela Ahmad	General Counsel & Secretary	N/D	N/D	N/D
Mr. Eric Khairy	Senior Vice President of Marketing	N/D	N/D	N/D
Mr. Tim Benner	Senior VP of Sales & Senior VP of U.S. Sales	N/D	N/D	N/D
Ms. Tara Dunn	Senior VP & GM of LimFlow	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

Governance aziendale

L'ISS Governance QualityScore di Inari Medical, Inc. al 1 aprile 2024 è 5. I criteri di valutazione fondamentali sono revisione: 2; Consiglio di Amministrazione: 5; diritti degli azionisti: 8; retribuzione: 6.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.